0001785530-21-000001.txt : 20210107 0001785530-21-000001.hdr.sgml : 20210107 20210107102706 ACCESSION NUMBER: 0001785530-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210107 DATE AS OF CHANGE: 20210107 EFFECTIVENESS DATE: 20210107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Werewolf Therapeutics, Inc. CENTRAL INDEX KEY: 0001785530 IRS NUMBER: 823523180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-385514 FILM NUMBER: 21513265 BUSINESS ADDRESS: STREET 1: 1030 MASSACHUSETTS AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 617-952-0555 MAIL ADDRESS: STREET 1: 1030 MASSACHUSETTS AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 D 1 primary_doc.xml X0708 D LIVE 0001785530 Werewolf Therapeutics, Inc. 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA MASSACHUSETTS 02138 617-952-0555 DELAWARE None None Corporation true 2017 Daniel Hicklin 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Executive Officer Director David Cordo 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Executive Officer Luke Evnin 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Briggs Morrison 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Derek DiRocco 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Sakae Asanuma 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Alon Lazarus 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Elise Wang 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Pharmaceuticals Decline to Disclose 06b false 2020-12-23 false true false 0 72069999 72069999 0 false 19 0 0 0 false Werewolf Therapeutics, Inc. /s/ Daniel Hicklin Daniel Hicklin President and Chief Executive Officer 2021-01-07